Peter Reimer

Peter Reimer

Auto-generated profile, based on publicly available information

Peter Reimer

Städtisches Klinikum Karlsruhe, Karlsruhe, Germany

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 October 2023 in European Radiology
Verified
Journal Article
Open access
PDF file
AMAart J van der Molen
Aart J van der Molen
IDIlona Dekkers
Ilona Dekkers
RGRemy Geenen
Remy Geenen
MBMarie-France Bellin
Marie-France Bellin
MBMichele Bertolotto
Michele Bertolotto
OCOlivier Clement
Olivier Clement
The pharmacokinetics of contrast media (CM) will determine how long safe waiting intervals between successive CT or MRI examinations should be. The Contrast Media Safety Committee has reviewed the data on pharmacokinetics of contrast media to suggest safe waiting intervals between successive contrast-enhanced imaging studies in relation to the renal function of the patient. Clinical relevance statement: Consider a waiting time between elective contrast-enhanced CT and (coronary) angiography with successive iodine-based contrast media administrations in patients with normal renal function (eGFR > 60 mL/min/1.73 m2) of optimally 12 h (near complete clearance of the previously administered iodine-based contrast media) and minimally 4 h (if clinical indication requires rapid follow-up). Key Points: • Pharmacokinetics of contrast media will guide safe waiting times between successive administrations. • Safe waiting times increase with increasing renal insufficiency. • Iodine-based contrast media influence MRI signal intensities and gadolinium-based contrast agents influence CT attenuation.

17 January 2018 in CardioVascular and Interventional Radiology
Verified
Journal Article
Closed access
PDF file
PRP. Reimer
P. Reimer
MVMAYUR VIRARKAR
MAYUR VIRARKAR
MBM. Binnenhei
M. Binnenhei
MJM. Justinger
M. Justinger
MSM. R. Schön
M. R. Schön
KTK. Tatsch
K. Tatsch

20 December 2019 in Experimental and Clinical Endocrinology & Diabetes
Verified
Journal Article
Closed access
PDF file
BBBernd Balletshofer
Bernd Balletshofer
WIWulf Ito
Wulf Ito
HLHolger Lawall
Holger Lawall
NMNasser Malyar
Nasser Malyar
YOYves Oberländer
Yves Oberländer
MZMarkus Zähringer
Markus Zähringer
This position paper is based on the current German and international guideline recommendations [1] [2] [3] and serves as a short, clinically-oriented guideline for the diagnosis and treatment of patients with diabetes mellitus and peripheral arterial disease (PAD). Peripheral circulatory disorders of the pelvic and leg arteries are one of the complications patients with diabetic mellitus suffer from. The term covers stenoses, occlusions and - to a lesser extent - aneurysmal vascular changes of the pelvic leg arteries. Arterial vascular lesions mostly occur in later life, however, people with diabetes mellitus are often affected prematurely. In these patients, the time of the initial manifestation also depends on the duration of the disease and the quality of metabolic control. Only 25% of affected patients have symptoms. Especially in patients with diabetes mellitus, atheroma of the peripheral vessels is aggravated by chronic inflammatory vessel wall processes and hypercoagulability. Second to nicotine abuse, diabetes is the most important risk factor for the occurrence of PAD [4]. Patients with diabetes have a 2 to 4-time higher risk of developing PAD than patients without diabetes. Up to 30% of all patients with claudication and 50% of all patients with critical limb ischemia (CLI) are people with diabetes mellitus [5]. PAD patients with diabetes have specific anatomical-morphological and clinical characteristics which must be considered in the diagnostic and therapeutic approach. Compared to people without diabetes mellitus, PAD in people with diabetes mellitus develops earlier, progresses more rapidly and more frequently changes over to critical limb ischemia (CLI). Anatomically-morphologically, a multi-segmental manifestation with long, calcified stenoses/occlusions of the lower leg arteries with insufficient collateral formation is typical. Clinically, people with diabetes mellitus often first consult their doctors because of a critical ischemia, in part because the intermittent claudication preceding a critical ischemia and the pain at rest can remain masked for a long time by the diabetic sensory polyneuropathy. The prognosis regarding a life without amputations is poor for people with diabetes mellitus. This is due, on the one hand, to the high ischemia and ulcer recurrence rates and the associated minor and major amputations, on the other hand it results from the high rate of comorbidities and co-prevalence of terminal organ damage such as cardiac and renal insufficiency, each of which on its own increases mortality. The most significant consequences of diabetic peripheral circulatory disorders are foot lesions (ulcers and gangrene) and minor and major amputations as a result of ischemic or neuro-ischemic diabetic foot syndrome (DFS) ([Table 1]).

4 April 2024 in European Radiology
Verified
Journal Article
Open access
PDF file
RGRemy Geenen
Remy Geenen
AMAart J. van der Molen
Aart J. van der Molen
IDIlona Dekkers
Ilona Dekkers
MBMarie-France Bellin
Marie-France Bellin
MBMichele Bertolotto
Michele Bertolotto
TBTorkel B. Brismar
Torkel B. Brismar
Objectives: Hysterosalpingography (HSG) is widely used for evaluating the fallopian tubes; however, controversies regarding the use of water- or oil-based iodine-based contrast media (CM) remain. The aim of this work was (1) to discuss reported pregnancy rates related to the CM type used, (2) to validate the used CM in published literature, (3) to discuss possible complications and side effects of CM in HSG, and (4) to develop guidelines on the use of oil-based CM in HSG. Methods: A systematic literature search was conducted for original RCT studies or review/meta-analyses on using water-based and oil-based CM in HSG with fertility outcomes and complications. Nine randomized controlled trials (RCTs) and 10 reviews/meta-analyses were analyzed. Grading of the literature was performed based on the Oxford Centre for Evidence-Based Medicine (OCEBM) 2011 classification. Results: An approximately 10% higher pregnancy rate is reported for oil-based CM. Side effects are rare, but oil-based CM have potentially more side effects on the maternal thyroid function and the peritoneum. Conclusions: 1. HSG with oil-based CM gives approximately 10% higher pregnancy rates. 2. External validity is limited, as in five of nine RCTs, the CM used is no longer on the market. 3. Oil-based CM have potentially more side effects on the maternal thyroid function and on the peritoneum. 4. Guideline: Maternal thyroid function should be tested before HSG with oil-based CM and monitored for 6 months after. Clinical relevance statement: Oil-based CM is associated with an approximately 10% higher chance of pregnancy compared to water-based CM after HSG. Although side effects are rare, higher iodine concentration and slower clearance of oil-based CM may induce maternal thyroid function disturbance and peritoneal inflammation and granuloma formation. Key Points: • It is unknown which type of contrast medium, oil-based or water-based, is the optimal for HSG. • Oil-based contrast media give a 10% higher chance of pregnancy after HSG, compared to water-based contrast media. • From the safety perspective, oil-based CM can cause thyroid dysfunction and an intra-abdominal inflammatory response in the patient.

26 August 2024 in CardioVascular and Interventional Radiology
Verified
Journal Article
Open access
PDF file
MCMaria Adriana Cocozza
Maria Adriana Cocozza
EDElton Dajti
Elton Dajti
LBLorenzo Braccischi
Lorenzo Braccischi
FMFrancesco Modestino
Francesco Modestino
PRPeter Reimer
Peter Reimer
Cristina MosconiCristina Mosconi
Cristina Mosconi
Purpose: Transarterial radioembolization (TARE) has emerged as a promising therapeutic approach for unresectable intrahepatic cholangiocarcinoma (ICCA). We updated our previous meta-analysis with meta-regression to explore the efficacy of TARE in the context of ICCA. Methods: We searched PubMed and Scopus for studies published up to September 1, 2023. The primary outcome was overall survival. Secondary outcomes were tumor overall response rate, severe adverse events, and downstaging to surgery. Meta-analysis employed a random-effects model, and meta-regression was utilized to explore sources of heterogeneity. Results: We included 27 studies, involving 1365 patients. Pooled survival estimates at 1, 2, and 3 years were 52.6%, 27%, and 16.8%, respectively. Meta-regression revealed that the proportion of patients naïve to treatment was the only pre-TARE predictor of survival (1-, 2-, and 3-year survival of 70%, 45%, and 36% for treatment-naïve patients, mean survival 19.7 months vs. 44%, 18%, and 7% for non-naïve patients, mean survival 12.2 months). Overall response according to RECIST 1.1 and mRECIST was 19.6% and 67%, respectively. Effective downstaging to surgery was possible in varying rates (3–54%); the mean survival in these patients was 34.8 months (1-, 2-, and 3-year survival of 100%, 87%, and 64%). About 45.7% of patients experienced adverse events, but only 5.9% were severe. Conclusions: Our study benchmarked the survival rates of patients undergoing TARE for unresectable ICCA and showed that this is a valid option in these patients, especially if naïve to previous treatments. Downstaging to surgery is feasible in selected patients with promising results. Graphical

11 March 2022 in CardioVascular and Interventional Radiology
Verified
Journal Article
Open access
PDF file
FGF. Gomez
F. Gomez
PRP. Reimer
P. Reimer
PPPhilippe L. Pereira
Philippe L. Pereira
CBC. Bent
C. Bent
RCR. L. Cazzato
R. L. Cazzato
GMG. Makris
G. Makris
Background: The COVID-19 pandemic had an unprecedented impact on clinical practice and healthcare professionals. We aimed to assess how interventional radiology services (IR services) were impacted by the pandemic and describe adaptations to services and working patterns across the first two waves. Methods: An anonymous six-part survey created using an online service was distributed as a single-use web link to 7125 members of the Cardiovascular and Interventional Radiological Society of Europe via email. Out of 450 respondents, 327 who completed the survey at least partially including 278 who completed the full survey were included into the analysis. Results: Interventional radiologists (IRs) reported that the overall workload decreased a lot (18%) or mildly (36%) or remained stable (29%), and research activities were often delayed (30% in most/all projects, 33% in some projects). Extreme concerns about the health of families, patients and general public were reported by 43%, 34% and 40%, respectively, and 29% reported having experienced significant stress (25% quite a bit; 23% somewhat). Compared to the first wave, significant differences were seen regarding changes to working patterns, effect on emergency work, outpatient and day-case services in the second wave. A total of 59% of respondents felt that their organisation was better prepared for a third wave. A total of 19% and 39% reported that the changes implemented would be continued or potentially continued on a long-term basis. Conclusion: While the COVID-19 pandemic has negatively affected IR services in terms of workload, research activity and emotional burden, IRs seem to have improved the own perception of adaptation and preparation for further waves of the pandemic.